API facility was made FDA compliant
. Entered Formulation Business
2006
Started Clinical Research and Biosciences
.Acquired formulation at Balanagar
2007
USFDA approval for API plant
2008
Obtained MHRA approval for CRBio (Project-based)
2009
.MOH Turkey approval for CRBio
.Japanese approval for API
2010
Expansion of API facility
2011
Expansion of CRBio facility
2012
USFDA Approval for API and CRBio facilities
2013
.USFDA Approval for Formulation facility
.EDQM Approval for API facility
2014
.Formulation Facility audited and cleared by COFEPRIS, MHRA & USFDA
2015
.API Facility Audited by COFEPRIS & EDQM
.API R&D facility was recognized by Department of Science and Industrial Research (DSIR), a government of India authority.
2016
Formulations R&D was recognized by Department of Science and Industrial Research (DSIR), a government of India authority.
